Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter H Watson

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
Breast Cancer Research : BCR|December 14, 2011
Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancerNathan R West, Katy Milne, Pauline T Truong, et al.
Breast Cancer Research : BCR|June 7, 2008
Jab1 is a target of EGFR signaling in ERalpha-negative breast cancerJiaxu Wang, Rebecca O Barnes, Nathan R West, et al.
Biopreservation and Biobanking|June 24, 2021
Vignettes to Illustrate the Value of Tumor Biobanks in Cancer Research in CanadaTamsin Tarling, Lise Anne Marie Matzke, Amanda Rush, et al.
Cancer Research|July 10, 2007
Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cellsErika M Wall, Katy Milne, Michele L Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2016
CD103 and Intratumoral Immune Response in Breast CancerZhi-Qiang Wang, Katy Milne, Heather Derocher, et al.
Biopreservation and Biobanking|December 8, 2017
An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating BiobanksRod Ling, Amanda Rush, Candace Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancerEthan D Emberley, Yulian Niu, Catherine Njue, et al.
The Journal of Pathology|June 29, 2004
The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in human tissues and tumoursHelen Turley, Charles C Wykoff, Sandra Troup, et al.
Cancer|April 28, 2011
Clinicopathologic factors of the recurrent tumor predict outcome in patients with ipsilateral breast tumor recurrenceValerie Panet-Raymond, Pauline T Truong, Cheryl Alexander, et al.
Oncotarget|September 9, 2017
PD-L1 and intratumoral immune response in breast cancerZhi-Qiang Wang, Katy Milne, Heather Derocher, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Breast Cancer Research : BCR|December 14, 2011
Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancerNathan R West, Katy Milne, Pauline T Truong, et al.
Breast Cancer Research : BCR|June 7, 2008
Jab1 is a target of EGFR signaling in ERalpha-negative breast cancerJiaxu Wang, Rebecca O Barnes, Nathan R West, et al.
Biopreservation and Biobanking|June 24, 2021
Vignettes to Illustrate the Value of Tumor Biobanks in Cancer Research in CanadaTamsin Tarling, Lise Anne Marie Matzke, Amanda Rush, et al.
Cancer Research|July 10, 2007
Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cellsErika M Wall, Katy Milne, Michele L Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2016
CD103 and Intratumoral Immune Response in Breast CancerZhi-Qiang Wang, Katy Milne, Heather Derocher, et al.
Biopreservation and Biobanking|December 8, 2017
An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating BiobanksRod Ling, Amanda Rush, Candace Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancerEthan D Emberley, Yulian Niu, Catherine Njue, et al.
The Journal of Pathology|June 29, 2004
The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in human tissues and tumoursHelen Turley, Charles C Wykoff, Sandra Troup, et al.
Cancer|April 28, 2011
Clinicopathologic factors of the recurrent tumor predict outcome in patients with ipsilateral breast tumor recurrenceValerie Panet-Raymond, Pauline T Truong, Cheryl Alexander, et al.
Oncotarget|September 9, 2017
PD-L1 and intratumoral immune response in breast cancerZhi-Qiang Wang, Katy Milne, Heather Derocher, et al.
Pageof 14